Drug intelligence / Profile preview

18F-MPPF

Development stage
Unknown
Lead developer
Hospices Civils de Lyon
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

18F-MPPF is a **fluorine-18 labeled positron emission tomography radioligand** used to image brain **serotonin 1A receptors** in vivo. It is an arylpiperazine-based small-molecule tracer that binds selectively and reversibly to the **5-hydroxytryptamine receptor 1A**, enabling PET quantification of regional receptor distribution and binding potential rather than delivering a direct therapeutic effect. In the context provided here, it is being developed by **Hospices Civils de Lyon** as an investigational imaging agent for PET-MRI studies in **Dravet syndrome** and **drug-resistant focal epilepsy**, with the goal of characterizing serotonergic pathway abnormalities in these disorders.

Other names
fluorine-18 MPPFfluorine18 MPPFfluorine 18 MPPF4-(2-methoxyphenyl)-1-[2-(N-2-pyridinyl)-p-[18F]fluorobenzamido]ethylpiperazine
02

Targets

HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))

Beyond the preview

Go deeper on 18F-MPPF.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 18F-MPPF.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call